Skip to main content
OpenTrials

Clinical trial condition

Acute Myeloid Leukemia (AML)

Explore clinical trials studying Acute Myeloid Leukemia (AML). Study availability and eligibility vary by location and protocol.

154 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Acute Myeloid Leukemia (AML) trial results

Completed

A Study of Oral Venetoclax Tablet in Combination With Subcutaneous Low-Dose Cytarabine (LDAC) Injection to Assess Adverse Events in Adult Japanese Participants With Acute Myeloid Leukemia (AML)

NCT04509622

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • NHO Nagoya Medical Center /ID# 223671 Nagoya, Aichi-ken, Japan
  • Aichi Cancer Center Hospital /ID# 223134 Nagoya, Aichi-ken, Japan
  • University of Fukui Hospital /ID# 223133 Yoshida-gun, Fukui, Japan
  • Kyushu University Hospital /ID# 223136 Fukuoka, Japan
View all 16 locations
View Trial Details
Completed

A Study of Venetoclax and Alvocidib in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT03441555

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • USC Norris Cancer Center /ID# 170844 Los Angeles, California, United States
  • UC Irvine /ID# 201093 Orange, California, United States
  • University of California, Davis Comprehensive Cancer Center /ID# 170799 Sacramento, California, United States
  • Sylvester Comprehensive Cancer /ID# 170761 Miami, Florida, United States
View all 14 locations
View Trial Details
Completed

A Study to Assess Safety and Efficacy of Venetoclax in Combination With Gilteritinib in Participants With Relapsed/Refractory Acute Myeloid Leukemia

NCT03625505

Conditions
Acute Myeloid Leukemia (AML), Disease Attributes, Hematologic Diseases, +9 more
Locations
  • David Geffen School of Medicin /ID# 200166 Los Angeles, California, United States
  • UC San Francisco Medical Center-Parnassus /ID# 200205 San Francisco, California, United States
  • Sylvester Comprehensive Cancer /ID# 200268 Miami, Florida, United States
  • Northwestern Memorial Hospital /ID# 200230 Chicago, Illinois, United States
View Trial Details
Completed

Study Evaluating Venetoclax in Subjects With Hematological Malignancies

NCT02265731

Conditions
Acute Myeloid Leukemia (AML), Blood Protein Disorders, Cardiovascular Diseases, +30 more
Locations
  • NHO Nagoya Medical Center /ID# 129222 Nagoya, Aichi-ken, Japan
  • Aichi Cancer Center Hospital /ID# 129061 Nagoya, Aichi-ken, Japan
  • Nagoya City University Hospital /ID# 129278 Nagoya, Aichi-ken, Japan
  • University of Fukui Hospital /ID# 165801 Yoshida-gun, Fukui, Japan
View all 14 locations
View Trial Details
Completed

Allogenic Stem Cell Transplantation for Children, Adolescents and Young Adults With Relapsed or Refractory AML

NCT00606723

Conditions
Acute Myeloid Leukemia (AML), Disease Attributes, Hematologic Diseases, +9 more
Locations
  • Graz University Hospital Graz, Austria
  • Innsbruck University Hospital Innsbruck, Austria
  • St. Anna Children Hospital Vienna, Austria
  • Teaching Hospital Motol Prague, Czechia
View all 24 locations
View Trial Details
Completed

Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine

NCT01180322

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Universitätsklinikum Innsbruck Innsbruck, Austria
  • Krankenhaus der Barmherzigen Schwestern Linz, Austria
  • Elisabethinen Krankenhaus Linz Linz, Austria
  • Landeskliniken Salzburg Salzburg, Austria
View all 44 locations
View Trial Details
Completed

Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)

NCT01242774

Conditions
Acute Myeloid Leukemia (AML), Chromosome Aberrations, Hematologic Diseases, +8 more
Locations
  • Stanford University Medical Center Stanford U Stanford, California, United States
  • Dana Farber Cancer Institute Beth Israel Deaconess Med Ctr Boston, Massachusetts, United States
  • Ohio State Comprehensive Cancer Center/James Cancer Hospital Dept.ofJamesCancerHospital Columbus, Ohio, United States
  • Medical University of South Carolina -Hollings Cancer Center MUSC/HCC (2) Charleston, South Carolina, United States
View Trial Details
Completed

A Phase Ib Study of Panobinostat (LBH589) in Combination With 5-Azacitidine for Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) Patients

NCT01613976

Conditions
Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +15 more
Locations
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Kobe, Hyōgo, Japan
  • Novartis Investigative Site Sendai, Miyagi, Japan
View Trial Details
Completed

PKC412, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT00093600

Conditions
Acute Myeloid Leukemia (AML), Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +7 more
Locations
  • Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States
  • Dana Faber Cancer Institute Boston, Massachusetts, United States
  • Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
  • MD Anderson Cancer Center/University of Texas Houston, Texas, United States
View Trial Details

Related conditions